CRISPR-based platforms such as SHERLOCK and DETECTR enable point-of-care testing, multiplexed detection, and portable diagnostics, transforming healthcare delivery in resource-limited settings.

This test is ... is a Houston-based molecular diagnostic solutions provider founded in July 2022. The mission is to advance disease detection and treatment by commercializing the CRISPR detection ...

This test is the first qualitative real-time polymerase chain reaction (PCR) assay to combine CRISPR technology, designed to detect Mycobacterium tuberculosis (Mtb) cell-free DNA in human serum ...